| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.5 | 7e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |